1.Advances in research on biology of B19 virus.
Xue-Li LIU ; Min WANG ; Zhuo-Zhuang LU ; Tao HONG
Chinese Journal of Virology 2011;27(6):599-603
2.Relationship between Myelodysplastic Syndrome and Epstein-Barr Virus or Human Parvovirus B19 Infection.
Kyung A LEE ; Jong Rak CHOI ; Kyung Soon SONG
Korean Journal of Clinical Pathology 1998;18(1):26-28
BACKGROUND: The mechanisms responsible for the disturbed hematopoiesis in myelodysplastic syndrome (MDS) include the expansion of abnormal clones, defects in cellular differentiation and the perturbation in the production of hematopoietic regulatory factors. Recently, viral infection such as immunodeficiency virus is known to induce myelodysplasia. And viral infection evokes the production of several cytokines. Therefore, abnormal production of cytokine may be a potential candidate for the pathogenesis of MDS after viral infections such as Epstein-Barr virus (EBV) and human parvovirus B19. METHODS: We investigated bone marrow aspiration slides from 17 patients with MDS referred for the bone marrow study, over a period from January, 1992 to April, 1996. To clarify the contribution of EBV and human parvovirus B19 infections to the pathogenesis of MDS, DNA-PCR for EBV and human parvovirus B19 was used. RESULTS: The EBV and human parvovirus B19-PCR results were all negative in 17 patients with MDS. CONCLUSIONS: EBV and human parvovirus B19 infections may not be associated with the major pathogenesis of MDS.
Bone Marrow
;
Clone Cells
;
Cytokines
;
Hematopoiesis
;
Herpesvirus 4, Human*
;
Humans*
;
Myelodysplastic Syndromes*
;
Parvovirus
;
Parvovirus B19, Human*
3.An Adult with Aplastic Crisis induced by Human Parvovirus B19 as an Initial Presentation of Hereditary Spherocytosis.
Sook Eui OH ; Jung Han KIM ; Chi Hun CHOI ; Kwang Hyuk PARK ; Joo Young JUNG ; Young Iee PARK ; Min Jeong PARK
The Korean Journal of Internal Medicine 2005;20(1):96-99
The association between aplastic crisis and human parvovirus (HPV) B19 infection is well described in patients with sickle cell anemia. This association has also been described, although much less frequently, in patients with hereditary spherocytosis (HS). However, most cases of aplastic crises in patients with HS and induced by HPV B19 have been reported in children or adolescents. In this paper, we describe an aplastic crisis induced by HPV B19 in an adult with HS. A 34-year-old female presented with presyncope, febrile sensation, and myalgia. The complete blood counts showed severe anemia. The peripheral blood smear revealed spherocytosis with reticulocytopenia and pancytopenia. The direct Coombs' test was negative; the osmotic fragility test was positive. In the bone marrow aspirates, a few giant pronormoblasts with deep blue cytoplasm, pseudopods, and intracellular inclusion bodies were observed. The patient was given eight units of packed red blood cells. HPV B19 infection was proven by the presence of IgM antibodies to HPV B19 and the detection of viral DNA using the PCR technique. To the best of our knowledge, this is the first report in Korea that describes an adult with aplastic crisis presenting initially with HS.
Adult
;
Anemia, Aplastic/*etiology
;
Female
;
Humans
;
Parvoviridae Infections/*complications/diagnosis
;
Parvovirus B19, Human
;
Spherocytosis, Hereditary/*diagnosis
4.Establishment of internally controlled real-time PCR for the detection of human parvovirus B19 DNA in serum.
Meng LI ; Xiao-Hui ZOU ; Min WANG ; Xiu-Ping YU ; Zhuo-Zhuang LU ; Tao HONG
Chinese Journal of Experimental and Clinical Virology 2010;24(6):479-481
OBJECTIVETo establish a TaqMan-based Real-time PCR assay with internal control for the detection of parvovirus B19 DNA in human serum.
METHODSTwo DNA fragments in length of 113 bp each were artificially synthesized, cloned into T vector and used as standard DNA or internal control, respectively. One pair of primers and two probes were included in the Real-time PCR. The probes were labeled with different fluoresceins and could bind B19 DNA or internal control, respectively. Precision and specificity of the method were evaluated. Specimens of human serum were examined by this assay to find B19 DNA.
RESULTSThe standard curve was constructed using the quantified standard B19 DNA. The Real-time PCR method was established. It was stable according to precision evaluation by the intra- and inter-assay and specific without any evident cross-reaction with human hepatitis B virus (HBV). Among 160 samples of human serum, B19 DNA was detected in 2 with a concentration of 2.1 x 10(5) Geq/ml and 3.6 x 10(3) Geq/ml, respectively.
CONCLUSIONThe Real-time PCR for B19 DNA detection was developed successfully, in which the internal control was helpful to exclude false-negative results.
DNA, Viral ; blood ; Humans ; Parvovirus B19, Human ; genetics ; Polymerase Chain Reaction ; methods
5.Detection of human parvovirus B19 nonstrutural protein DNA by nested-polymerase chain reaction in gravida serum and pregnant tissues.
Ting, SHEN ; Yongmei, HUANG ; Fuyuan, QIAO ; Zengqing, LI ; Haiyi, LIU
Journal of Huazhong University of Science and Technology (Medical Sciences) 2006;26(1):123-6
A new nested-polymerase chain reaction (nested-PCR) assay was developed to detect human parvovirus B19 DNA corresponding to the nonstructural protein in clinical specimens in a routine diagnostic laboratory. The sensitivity of this highly specific assay was up to 0.005 fg of B19 DNA. Parvovirus B19 was identified in sera of 20 pregnant women with abnormal pregnant outcome. Among these 20 cases, intrauterine parvovirus infection did exist in 7 pregnant women because parvovirus B19 DNA was detected in the pregnant tissues of them such as placenta tissues, chorionic villi, amniotic fluid, fetal spleen, liver and abdominal fluids.
DNA, Viral/*analysis
;
Parvoviridae Infections/*virology
;
Parvovirus B19, Human/genetics
;
Parvovirus B19, Human/*isolation & purification
;
Placenta/virology
;
Pregnancy Complications, Infectious/diagnosis
;
Pregnancy Complications, Infectious/*virology
;
Viral Nonstructural Proteins/*analysis
6.Does Human Parvovirus B19 have a Role in the Formation of the Anemia and the Disease Activity in Rheumatoid Arthritis?.
Korean Journal of Clinical Pathology 2001;21(4):287-291
BACKGROUND: The pathogenic human parvovirus B19 replicates only in erythroid progenitor cells. The blood-group P antigen has been reported to be the cellular receptor of this virus. Human parvovirus B19 is known to be the etiologic agent of erythema infectiosum and causes a chronic anemia resulting from a persistent infection in immunocompromised patients. Recently, it has been re-ported to play a role in rheumatoid arthritis activity (RA). This study was aimed to determine whether human parvovirus B19 has a role to play in chronic anemia of RA which is the case in immunocompromised patients. We also investigated the association between the activity of the disease in RA and human parvovirus B19 infections. METHODS: Of 107 patients that had RA, 49 patients had anemia and 58 patients did not. We used ESR and CRP results to estimate the degree of disease activity. Thirty-eight patients having RA had a normal ESR and 69 patients had a high ESR. Sixty patients had normal CRP and 47 patients had high CRP. Sera of patients were tested for the presence of anti-human parvovirus B19 (IgG and IgM) using ELISA (Biotrin, Co. Dublin, Ireland). RESULTS: Of 107 patients who had RA, 79.4% (85/107) and 3.7% (4/107) were positive for IgG and IgM, respectively. There were no statistical differences between RA patients with anemia and those without anemia in the anti-human parvovirus B19 test (P>0.05). There were also no statistical differences between patients that had a normal or high ESR/CRP ratio (P>0.05). CONCLUSIONS: Human parvovirus B19 did not play a role in the formation of the chronic anemia of RA which is different from the cases of immunocompromised patients. Furthermore, we found no association between disease activity in RA and human parvovirus B19 infections.
Anemia*
;
Arthritis, Rheumatoid*
;
Enzyme-Linked Immunosorbent Assay
;
Erythema Infectiosum
;
Erythroid Precursor Cells
;
Humans*
;
Immunocompromised Host
;
Immunoglobulin G
;
Immunoglobulin M
;
Parvovirus
;
Parvovirus B19, Human*
7.Human Parvovirus B19 Infection in Patients with Fibromyalgia.
Hyun Jung YOON ; Shin Seok LEE
The Journal of the Korean Rheumatism Association 2005;12(1):38-41
OBJECTIVE: The association of parvovirus B19 infection with many rheumatologic disease, including systemic lupus erythematosus, rheumatoid arthritis, Sjogren's syndrome, polymyositis has been suggested, although the exact relationship between the infection and these disorders is not understood. Several cases of fibromyalgia have been reported after parvovirus B19 infection, but systemic investigation of parvovirus B19 infection in Korean patients with fibromyalgia has not been performed. This study was designed to investigate the clinical significance of human parvovirus B19 infection in Korean patients with fibromyalgia. METHODS: Serum from 54 patients with fibromyalgia and 61 age and sex matched healthy controls were tested for IgM and IgG anti-parvovirus B19 antibodies by two different commercially available ELISA kits and presence of parovovirus B19 DNA was measured by PCR. RESUTLS: IgM antibodies to parvovirus B19 were detected 1 fibromyalgia patient in one assay and 1 patient in the other assay. No controls had positive IgM antibodies. No difference was seen between fibromyalgia patients and controls with the IgG andtibodies to parvovirus B19 in two different assays. Parvovirus B19 DNA was detected in 3 fibromyalgia patients, but not in controls. CONCLUSION: Our data showed that fibromyalgia could be triggerd by parvovirus B19 infection, but parvovirus B19 is unlikely to play a significant role in the pathogenesis of Korean patients with fibromyalgia.
Antibodies
;
Arthritis, Rheumatoid
;
DNA
;
Enzyme-Linked Immunosorbent Assay
;
Fibromyalgia*
;
Humans*
;
Immunoglobulin G
;
Immunoglobulin M
;
Lupus Erythematosus, Systemic
;
Parvovirus
;
Parvovirus B19, Human*
;
Polymerase Chain Reaction
;
Polymyositis
;
Sjogren's Syndrome
8.Screening of Apheresis Platelet Donors for Human Parvovirus B19 by Gel Card Test.
Seung Ok LEE ; Jin Mee HWANG ; Jihyang LIM ; Yonggoo KIM ; Jong Wook LEE ; Ye RI ; Ja PARK ; Kyungja HAN ; Chun Choo KIM
Korean Journal of Blood Transfusion 1999;10(2):215-220
BACKGROUND: As apheresis platelet concentrates are widely used recently, the risk of transfusion associated infections is increased. Parvovirus B19 causes transfusion associated infections especially in chronic hemolytic anemia, haemophilia or immunosuppressed patients. We evaluated the significance of Parvovirus B19 antigen test to be one of the apheresis platelet donor screening test. METHODS: Three hundred forty eight serum (or plasma) samples from apheresis platelet donors were tested for Parvovirus B19 antigen test which was based on haemagglutination in gel technology. The tubes arranged in special gel cards (DiaMed) were added with 25 microL P antigen positive red cell and 10 microL patient's serum and then centrifuged at room temperature, 85 g for 10 minutes without incubation. The result was read and scored from 0 to 4 positive. Also the antibody screening test was performed for all of the positive samples on the Parvovirus B19 gel card test to exclude false positive reaction due to red cell alloantibody. We investigated directed recipient's disease state for all of positive donors and compared the result of the Parvovirus B19 antigen test with the routine screening test. RESLUTS: Six of the 348 samples were positive for Parvovirus B19 antigen test, the frequency was 1.7%. All of the six positive samples on gel card test reveal negative result by the antibody screening test. All of four directed recipients are immunosuppressed states. If the Parvovirus B19 antigen test was included in routine screening test, the rejection rate is expected to be increased about 1.4%. CONCLUSION: Screening for Parvovirus B 19 in apheresis platelet donors is considered to prevent transfusion mediated viral infection of susceptible recipients including immunocompromised patients.
Anemia, Hemolytic
;
Blood Component Removal*
;
Blood Platelets*
;
Donor Selection
;
False Positive Reactions
;
Hemophilia A
;
Humans
;
Humans*
;
Immunocompromised Host
;
Mass Screening*
;
Parvovirus
;
Parvovirus B19, Human*
;
Tissue Donors*
9.A Case of Gloves and Socks Syndrome.
Hae Hong JEONG ; Jun Gyu JANG ; Young Soo CHAE ; Kee Suck SUH ; Sang Tae KIM
Korean Journal of Dermatology 1998;36(3):536-539
Clinical characteristics of papular-purpuric gloves and socks syndrome consist of a purpuric erythema affecting the hands and feet in a gloves and stocking distribution. It is sometimes associated with fever and oral lesions. The disease is self-limiting and resolves within 1 to 2 weeks. Serological studies have shown that there is an association with parvovirus B19 infection in most patients affected by this syndrome. We report a case of gloves and socks syndrome in a 21-year-old female. She had a 4-day history of papular-purpuric eruptions of the hands and feet in a gloves-and-socks distribution. She also complained of fever(up to 39C) during the first 2 or 3 days of clinical onset. The oral mucosa was normal and there were no palpable lymph nodes. Laboratory and histopathological findings were non-specific. However, human parvovirus B19 DNA was detected in the serum by a polymerase chain reaction. Systemic manifestations were transient and disappeared within a few days, whereas the skin lesions resolved gradually over a period of 2 weeks.
DNA
;
Erythema
;
Female
;
Fever
;
Foot
;
Hand
;
Humans
;
Lymph Nodes
;
Mouth Mucosa
;
Parvovirus
;
Parvovirus B19, Human
;
Polymerase Chain Reaction
;
Skin
;
Young Adult
10.Human parvovirus B19 and parvovirus 4 among Iranian patients with hemophilia.
Davod JAVANMARD ; Masood ZIAEE ; Hadi GHAFFARI ; Mohammad Hasan NAMAEI ; Ahmad TAVAKOLI ; Hamidreza MOLLAEI ; Mohsen MOGHOOFEI ; Helya Sadat MORTAZAVI ; Seyed Hamidreza MONAVARI
Blood Research 2017;52(4):311-315
BACKGROUND: Human parvovirus B19 (B19V) is one of the smallest DNA viruses and shows great resistance to most disinfectants. Therefore, it is one of the common contaminant pathogens present in blood and plasma products. Parvovirus 4 (PARV4) is a newly identified parvovirus, which is also prevalent in parenteral transmission. In this study, we aimed to evaluate the prevalence of B19V and PARV4 DNA among patients with hemophilia in Birjand County in eastern Iran. METHODS: This was a cross-sectional epidemiological study comprising nearly all people with hemophilia in this region. Whole blood samples were taken after patient registration and sent for plasma isolation. After nucleic acid extraction, B19V was detected with real-time polymerase chain reaction, PARV4 DNA was then detected using sensitive semi-nested PCR. RESULTS: In total, there were 86 patients with hemophilia, with mean age 28.5±1.5 years. Of these, 90.7% were men and 9.3% women; 84.9% had hemophilia A and 7.0% had hemophilia B. We found 11 patients (12.8%) were positive for B19V DNA and 8 were positive (9.3%) for PARV4 DNA. The prevalence of B19V was higher in middle-aged groups rather than younger people, whereas PARV4 infection was more common in younger patients (P < 0.05). CONCLUSION: There was a high prevalence of B19V and PARV4 infection in this high-risk group of patients with hemophilia. Due to the clinical significance of the B19 virus, imposing more precautionary measures for serum and blood products is recommended.
Disinfectants
;
DNA
;
DNA Viruses
;
Epidemiologic Studies
;
Female
;
Hemophilia A*
;
Hemophilia B
;
Humans*
;
Iran
;
Male
;
Parvovirus B19, Human*
;
Parvovirus*
;
Plasma
;
Polymerase Chain Reaction
;
Prevalence
;
Real-Time Polymerase Chain Reaction